API
CNMD icon

Advisor Partners II’s CONMED CNMD Stock Holding History

Advisor Partners II’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$296K Buy
2,932
+1,419
+94% +$163K 0.01% 963
2023
Q2 		$206K Buy
+1,513
New +$185K 0.01% 995

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Advisor Partners II's CNMD Position: Q3 2023 in Review

Advisor Partners II increased its CONMED (CNMD) stake by 94% in Q3 2023, buying an estimated $163K and bringing the position to 2,932 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #963.

Advisor Partners II first reported a position in CNMD in Q2 2023 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

  • Advisor Partners II held 2,932 shares of CONMED worth $296K as of Q3 2023.
  • Advisor Partners II bought 1,419 CONMED shares in Q3 2023, an estimated $163K.
  • CONMED made up 0.01% of Advisor Partners II's portfolio in Q3 2023, its #963 holding.
  • Advisor Partners II first reported a position in CONMED in Q2 2023 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.